News - Diabetes care

One Drop partners with Amazon’s Choice to expand health services offering

One Drop, a leader in the development of digital therapeutics solutions for people with diabetes and related conditions, today announced a partnership with Amazon's exclusive health brand, Choice.

ForaCare launches new diabetes monitoring system

ForaCare, Inc. US this week announced the launch of its FOR A GTel Multi-Functional Monitoring System with built-in cellular connectivity.

World Sleep Day: The Dreem smart headband developing healthy sleeping habits

With its brain-activity monitoring tools, sleep science company Dreem is solving sleep-related problems of chronic insomnia affecting 10% of the worlds population, which World Sleep Day is addressing today

Nemaura Medical announces exclusive license and supply deal for SugarBEAT in GCC Region

Nemaura Medical, a medical technology company focused on the development of SugarBEAT as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by diabetics and pre-diabetics, has signed an exclusive license and supply agreement for SugarBEAT with TPMENA in the Gulf Cooperation Council (GCC) Region, which includes Bahrain, Kuwait, Saudi Arabia, Oman and United Arab Emirates.

Tandem Diabetes Care approved as insulin pump vendor for ADP in Ontario, Canada

Tandem Diabetes Care, an insulin delivery and diabetes technology company, announced that it is now registered as an approved vendor of insulin pumps and supplies under the Assistive Devices Program (ADP) in Ontario, Canada.

Tandem Diabetes Care announces plan to use remote software update tool in ongoing clinical trial

Tandem Diabetes Care, a leading insulin delivery and diabetes technology company, announced that it intends to use its remote software update tool, the Tandem Device Updater, to resolve a Control-IQ technology software anomaly identified during the ongoing DCLP3 phase of the International Diabetes Closed Loop (IDCL) clinical trial.

Healthagen to study real-world application of Welldoc’s OneTouch Reveal Plus among type 2 diabetes patients

Healthagen, an Aetna business unit within CVS Health, and Welldoc, in collaboration with LifeScan, announced details of a study to evaluate the use and potential health benefits of OneTouch Reveal Plus.

Senseonics Eversense CGM launches integration with Glooko

Senseonics Holdings, a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced the integration of Eversense CGM data into the Glooko diabetes data management platform.

Rani Therapeutics announces first human study of robotic RaniPill capsule to replace injections

The first human study of a pill designed to replace injections of biologics is today being announced by Rani Therapeutics, the inventor of the RaniPill capsule.